Mednet Logo
HomePediatric Hematology/Oncology
Pediatric Hematology/Oncology

Pediatric Hematology/Oncology

Clinical discussions on pediatric blood disorders, childhood cancers, and specialized treatment protocols.

Recent Discussions

What is your surveillance approach for outpatient monitoring of ICI myocarditis?

2 Answers

Mednet Member
Mednet Member
Cardiology · UConn Health

Screening and surveillance strategies for outpatient monitoring of ICI myocarditis are not well-defined. The best surveillance approach would be based on clinical risk assessment, followed by biomarker and imaging data. The risk factors for ICI myocarditis remain to be clarified, but the most valida...

Which biomarkers or diagnostic tools do you prioritize to support the decision to start antifungal treatment in septic patients with no clear source of infection but at high risk for fungal infections?

3
4 Answers

Mednet Member
Mednet Member
Infectious Disease · Ut Physicians Infectious Diseases Texas Medical Center

In general terms we do not use biomarkers to decide to start antifungals in a septic patient. We use them to confirm or rule out the infection once the antifungals were started based on clinical suspicion/presentation. BDG in particular has very good negative predictive value for candidemia, but due...

What is your strategy for managing immunosuppression in patients with a kidney transplant who develop metastatic cancer?

1
3 Answers

Mednet Member
Mednet Member
Nephrology · University of Alabama Birmingham

This is a difficult situation. I presume this question refers to cancers for which there is no option of cure. We always discuss the goals of care and review with the patient and their treating oncologist what the prognosis might be. If chemotherapy or check-point inhibitor treatment is planned we ...

Do you adjust chemotherapy dose if >=10% change in calculated dose, weight, BSA, or if any of these three parameters are met?

1
2 Answers

Mednet Member
Mednet Member
Medical Oncology · Fox Chase Cancer Center

Our institution has a policy of adjusting chemotherapy doses if there is a 10% change in calculated dose. Since some drugs are based on weight and some on BSA, it gets complicated if we stick with one versus the other. Also, this practice aligns with ASCO recommendations.

How will you treat an uterine embryonal rhabdomyosarcoma with regional node involvement resected to involved parametrial margins?

1
1 Answers

Mednet Member
Mednet Member
Radiation Oncology · University of Kentucky

It's hard for me to say how I would treat the patient as described without a bit more information and review of the case. So, I will make a few general comments. One major question is, "What is the age of the patient?". And I assume from the question that the parametrial margins were involved. Two t...

How would you manage a patient with sickle cell disease who is infected with COVID-19?

1
1 Answers

Mednet Member
Mednet Member
Pediatric Hematology/Oncology · Children's Hospital of Michigan

We have limited knowledge about this management. The Sickle Cell Disease Association of America's Medical and Research Advisory Committee has issued a provider advisory. Also, Dr. Julie Paniepento has created a registry that can be viewed in real time here: https://covidsicklecell.org/ In general, t...

Is there evidence to support or argue against intermittent fasting for cancer patients?

6
3 Answers

Mednet Member
Mednet Member
Radiation Oncology

This is a complex topic with many permutations of dietary interventions similar to fasting such as calorie restriction and “fasting mimicking”, but as it pertains to pure fasting, I know of a few small studies which characterize fasting around the time of chemotherapy infusions (Raffaghello et al., ...

How do you differentiate demoralization from depression during cancer treatment?

5
2 Answers

Mednet Member
Mednet Member
Psychiatry · Massachusetts General Hospital/Harvard Medical School

Certainly a key question in all referrals for "depression" in psycho-oncology. The two syndromes have areas of overlap and are not mutually exclusive. Clinical depression in cancer looks much like it would in any other context, though non-specific physical symptoms that can be caused by the cancer/t...

Would use of proton radiation versus photon radiation in neuroblastoma patients post autologous stem cell transplant reduce the risk of transplant associated-TMA?

2
1 Answers

Mednet Member
Mednet Member
Pediatric Hematology/Oncology · Kapiolani Medical Center For Women & Children

Transplant-Associated Thrombotic Microangiopathy arises partially due to injury to the endothelium; it is one of the “endothelial injury complications” of hematopoietic stem cell transplantation (HSCT), along with veno-occlusive disease (VOD) and engraftment syndrome (ES), among others. There is a w...

Does your evaluation of a young person with spontaneous upper extremity DVT vary as compared to lower extremity DVT?

2
1 Answers

Mednet Member
Mednet Member
Hematology · University of Rochester School of Medicine and Dentistry

The workup for a young adult with an upper extremity DVT differs for me in two ways: Venous thoracic outlet syndrome must be suspected and a careful history of repetitive overhead movements must be obtained. Consulting your vascular surgery team in these cases to ensure the anatomy does not put the...